Cancer Registry Software Market

SKU: DMAG3408 | Last Updated On: May 27 2021 | No. of Pages: 180 | Available Formats

> Global Cancer Registry Software Market Expected to reach a high CAGR By 2028: DataM Intelligence

Global Cancer Registry Software Market is segmented By Type (Standalone Software, Integrated Software), By Deployment Model (On-premise, Cloud-based), By Database (Commercial Databases, Public Databases), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

Market Overview

The Global Cancer Registry Software Market is expected to grow at a CAGR during the forecasting period (2021-2028).

A cancer registry software is an information system or computerized database to manage and collect the data associated with cancer patients. This data helps in the evaluation of trends and eventually enhances cancer patient care. As per the World Health Organization, cancer killed about 9.6 million people in 2018. The data demonstrates the need for cancer registry software and has facilitated the expansion of the global cancer registry software market in the forecast period. Initiatives taken by governments to increase the use of cancer registries have also augmented the market’s frontiers.

Source: DataM Intelligence Analysis (2020)

Market Dynamics

The cancer registry software market growth is driven by increasing prevalence of cancer and favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, increasing adoption of EHRs, and growing use of cancer patient registry data for post-marketing surveillance.

Rise in the adoption of electronic health records (EHR) has driven the market

The surge in the adoption of electronic health records (EHR) is the critical constituent promoting the development of the cancer registry software market. Moreover, healthcare professionals are focusing on increasing the quality of concern for cancer patients. It will only be accomplished by analyzing the trends repeatedly and taking actions accordingly, thereby increasing cancer registry software.

Governments of numerous countries are taking initiatives to encourage the adoption of the cancer registry software. In addition to this, customization of standard software for patient registries facilitating automatic upgradation and multiple system usage has spiked the global cancer registry system’s market. The development of new cancer registry software has further supported the market’s growth.

For instance, Elekta has developed a novel cancer registry data administration software called METRIC. It displays various functions such as workflow management, remote abstracting, data validation, and population and careful analysis. These functions are carried out in a 24/7 guarded data center using abstract configuration, follow-up manager. This tool has gained immense popularity in the global cancer registry market, mainly due to its ease of use. It offers simple navigation and efficient follow-up that includes status updates, history, schedules, control lists, and letters. Moreover, it has significantly reduced operating costs with the help of efficient workflow tools..

The availability of free software programs for cancer registry is driving the market growth

The availability of free software applications for cancer registries plays a crucial role in increasing the global cancer registry software market. Registry Plus is a suite of such free cancer registry software programs for individual or routine data collection. It includes a central registry database program called the CRS plus and a web application that collects cancer data across the internet. Moreover, it is submissive to the national standards, which has helped extensive adoption of this product.

Safety and privacy of the data may pose a challenge to the market’s growth

Cancer patient registries include health report data that may include a broad array of demographic data and personal characteristics such as socioeconomic and marital status, formal education, developmental disabilities, cognitive capacities, emotional stability, gender, age, and race. Also, health data generally covers information about the patients’ family members. As a result, in the circumstances of a data breach, the individual, confidential information of patients and third parties can come into the wrong hands. In the healthcare industry, ~30% of data breaks result in medical identity theft, mainly due to a lack of internal control over patient information, top management assistance, obsolete policies and schemes, non-adherence to existing ones, and inadequate resources personnel training. Governments of many countries in developed markets are currently trying to address and coordinate the consolidated needs of privacy and freedom of information.

COVID-19 Impact Analysis

Due to COVID, all the hospitals are given preference to the affected patients. Also, many hospitals are full due to the COVID-affected patients. The medical staff and paramedics are also busy in the treatment of COVID-positive patients. Thus there is a minimum use or no use of this software in the present situation. This factor will hamper the market growth in the forecast period.

Segment Analysis

By type, the cancer registry software market is classified into standalone software and  integrated software.

Standalone Software segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)   

Standalone Software summarizes medical records into an electronic report of cancer diagnosis and treatment. It supports the abstraction of all data items in national standard data sets, including all text fields and any state-specific data items. Its output is an electronic abstract in the North American Association of Central Cancer Registries (NAACCR) data exchange layout format.

Central cancer registries can customize Abstract Plus to be used centrally and by hospitals, clinics, laboratories, and other cancer data sources. Clients should not make any changes (additions, modifications, deletions) to the database schema objects without written approval from CDC.

On the basis of database, the the cancer registry software market is classified into commercial databases amd  public databases.

The commercial databases segment are expected to dominate the cancer registry software market during the forecast period  

Commercial databases for cancer is  has the larger share in the forecast period. The database sourced from hospital registry data that are collected in more than 1,500 Commission on Cancer (CoC)-accredited facilities. NCDB data are used to analyze and track patients with malignant neoplastic diseases, their treatments, and outcomes. Data represent more than 70 percent of newly diagnosed cancer cases nationwide and more than 34 million historical records. Online reporting tools are available to provide your program with comparative benchmarks for similar programs aggregated throughout your state, region, and across CoC-accredited programs as a whole. Additional reporting tools provide quality related performance measures in comparison to aggregated CoC-accredited programs, including quality improvement, quality assurance, and surveillance measures.

Source: DataM Intelligence Analysis (2020)

Geographical Analysis

North America region holds the largest market share in the global cancer registry software market

North America region is dominating the global cancer registry software market accounted for the largest market share in 2020. Factors such as the high burden of cancer, government funding initiatives to encourage the development of cancer registries, high investments in healthcare IT, the presence of significant cancer registry software development market players, and the high adoption rate of these solutions in the region are contributing to the larger share of North America in the cancer registry software market.

In the US, federal agencies such as the NIH, CDC, CMS, and AHRQ, along with several state agencies, are focusing on developing cancer patient registries to determine the long-term outcomes of agents, devices, groups of drugs, or procedures. The National Program of Cancer Registries (NPCR), administered by the US CDC, funded 50 cancer registries in the US in 2018 to promote the monitoring of the cancer burden at the state and national levels and evaluating activities in cancer prevention and control.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

The cancer registry software market is moderately competitive with presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Siemens Healthineers , Onco, Inc, C/Net Solutions, Elekta AB, Rocky Mountain Cancer Data Systems, Electronic Registry Systems, Inc, Mckesson Corporation, Ordinal Data, Inc, Conduent, Inc, IBM, Himagine solutions inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the cancer registry software market globally.    

Siemens Healthineers

Overview: Siemens Healthineers is a Germany-based company that provides technology to the healthcare sector companies. The Company has a wide range of products and services in laboratory and point of care diagnostics, diagnostic and therapeutic imaging and molecular medicine. It supplies medical technology and software solutions and clinical consulting services. Additionally, the Company is expanding its digital health and business services through increasing precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value.

Product Portfolio: The Company’s portfolio comprised of medical imaging, laboratory diagnostics, point-of-care testing, and Healthcare IT, accessories and equipment’s, and other areas.

Why Purchase the Report?

  • Visualize the composition of the cancer registry software market segmentation by type, deployment model, database and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in cancer registry software market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of cancer registry software market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global cancer registry software market report would provide an access to an approx. 69 market data table, 60 figures and 200 pages.  

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Suggestions for Related Market Report:

  • Global Cancer Stem Cells Market
  • Global Cancer Vaccines Market
  • Global Cancer Cachexia Market
  • Global Thymus Cancer Market

Table of Contents

  1. Global Cancer Registry Software Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Cancer Registry Software Market – Market Definition and Overview

  3. Global Cancer Registry Software Market – Executive Summary

    1. Market Snippet by Type
    2. Market Snippet by Deployment Model
    3. Market Snippet by Database
    4. Market Snippet by End User
    5. Market Snippet by Region
  4. Global Cancer Registry Software Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Rise in the adoption of electronic health records (EHR) has driven the market
        2. The availability of free software programs for cancer registry is driving the market growth  
      2. Restraints:
        1. Safety and privacy of the data may pose a challenge to the market’s growth
      3. Opportunity
      4. Impact Analysis
  5. Global Cancer Registry Software Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
    5. Reimbursement Analysis
    6. Unmet Needs
  6. Global Cancer Registry Software Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Cancer Registry Software Market – By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
      2. Market Attractiveness Index, By Type  Segment
    2. Standalone Software*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Integrated Software
  8. Global Cancer Registry Software Market – By Deployment Model

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      2. Market Attractiveness Index, By Deployment Model
    2. On-premise*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Cloud-based
  9. Global Cancer Registry Software Market – By Database

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      2. Market Attractiveness Index, By Database
    2. Commercial Databases*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Public Databases
  10. Global Cancer Registry Software Market – By End User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
      2. Market Attractiveness Index, By End User Segment
    2. Hospitals *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Clinics
    4.  Ambulatory Surgical Centers  
  11. Global Cancer Registry Software Market – By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  12. Global Cancer Registry Software Market – Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
  13. Global Cancer Registry Software Market- Company Profiles

    1. Siemens Healthineers*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Onco, Inc
    3. C/Net Solutions
    4. Elekta AB
    5. Rocky Mountain Cancer Data Systems
    6. Electronic Registry Systems, Inc
    7. Mckesson Corporation
    8. Ordinal Data, Inc
    9. Conduent, Inc
    10. IBM(*LIST NOT EXHAUSTIVE)
  14. Global Cancer Registry Software Market – DataM   

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables

Table 01   Global Cancer Registry Software Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table 02   Global Cancer Registry Software Market Value, By Deployment Model, 2020, 2024 & 2028 ($ Million)

Table 03   Global Cancer Registry Software Market Value, By  Database, 2020, 2024 & 2028 ($ Million)

Table 04   Global Cancer Registry Software Market Value, By End User, 2020, 2024 & 2028 ($ Million)

Table 05   Global Cancer Registry Software Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 06   Global Cancer Registry Software Market Value, By Type, 2020, 2024 & 2028 ($ Million)

Table 07   Global Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 08  Global Cancer Registry Software Market Value, By Deployment Model, 2020, 2024 & 2028 ($ Million)

Table 09   Global Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 10   Global Cancer Registry Software Market Value, By  Database, 2020, 2024 & 2028 ($ Million)

Table 11    Global Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 12   Global Cancer Registry Software Market Value, By End User, 2020, 2024 & 2028 ($ Million)

Table 13   Global Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 14   Global Cancer Registry Software Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 15   Global Cancer Registry Software Market Value, By Region, 2018-2028($ Million)

Table 16   North America Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 17    North America Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 18   North America Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 19   North America Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 20   North America Cancer Registry Software Market Value, By Country, 2018-2028($ Million)

Table 21   South America Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 22   South America Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 23   South America Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 24   South America Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 25   South America Cancer Registry Software Market Value, By Country, 2018-2028($ Million)

Table 26   Europe Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 27   Europe Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 28   Europe Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 29   Europe Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 30   Europe Cancer Registry Software Market Value, By Country, 2018-2028($ Million)

Table 31   Asia-Pacific Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 32   Asia-Pacific Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 33   Asia-Pacific Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 34   Asia-Pacific Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 35   Asia-Pacific Cancer Registry Software Market Value, By Country, 2018-2028($ Million)

Table 36   Middle East & Africa Cancer Registry Software Market Value, By Type, 2018-2028($ Million)

Table 37   Middle East & Africa Cancer Registry Software Market Value, By Deployment Model, 2018-2028($ Million)

Table 38   Middle East & Africa Cancer Registry Software Market Value, By  Database, 2018-2028($ Million)

Table 39   Middle East & Africa Cancer Registry Software Market Value, By End User, 2018-2028($ Million)

Table 40   Siemens Healthineers : Overview

Table 41   Siemens Healthineers : Product Portfolio

Table 42   Siemens Healthineers : Key Developments

Table 43   Onco, Inc: Overview

Table 44   Onco, Inc: Product Portfolio

Table 45   Onco, Inc: Key Developments

Table 46   C/Net Solutions: Overview

Table 47   C/Net Solutions: Product Portfolio

Table 48   C/Net Solutions: Key Developments

Table 49   Elekta AB: Overview

Table 50   Elekta AB: Product Portfolio

Table 51   Elekta AB: Key Developments

Table 52   "Rocky Mountain Cancer Data Systems: Overview"

Table 53   "Rocky Mountain Cancer Data Systems: Product Portfolio"

Table 54   "Rocky Mountain Cancer Data Systems: Key Developments"

Table 55   Electronic Registry Systems, Inc: Overview

Table 56   Electronic Registry Systems, Inc: Product Portfolio

Table 57   Electronic Registry Systems, Inc: Key Developments

Table 58   Mckesson Corporation: Overview

Table 59   Mckesson Corporation: Product Portfolio

Table 60   Mckesson Corporation: Key Developments

Table 61   Ordinal Data, Inc: Overview

Table 62   Ordinal Data, Inc: Product Portfolio

Table 63   Ordinal Data, Inc: Key Developments

Table 64   "Conduent, Inc: Overview"

Table 65   "Conduent, Inc: Product Portfolio"

Table 66   "Conduent, Inc: Key Developments"

Table 67   IBM: Overview

Table 68   IBM: Product Portfolio

Table 69   IBM: Key Developments

List of Figures

Figure 01 Global Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 02 Global Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 03 Global Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 04 Global Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 05 Global Cancer Registry Software Market Share, By Region, 2020 & 2028 (%)

Figure 06 Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 07 Global Cancer Registry Software Market Y-o-Y Growth, By Type, 2020-2028 (%)

Figure 08 Standalone Software: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 09 Integrated Software: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 10 Global Cancer Registry Software Market Y-o-Y Growth, By Deployment Model, 2020-2028 (%)

Figure 11  On-premise: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 12 Cloud-based: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 13 Global Cancer Registry Software Market Y-o-Y Growth, By Database, 2020-2028 (%)

Figure 14 "Commercial Databases: Global Cancer Registry Software Market Value, 2018-2028($ Million)"

Figure 15 Public Databases: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 16 Global Cancer Registry Software Market Y-o-Y Growth, By End User, 2020-2028 (%)

Figure 17  Hospitals & Diagnostic Imaging Centers: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 18 Government Institutions: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 19 Research Facilities: Global Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 20 Global Cancer Registry Software Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure 21 North America Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 22 North America Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 23 North America Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 24 North America Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 25 North America Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 26 North America Cancer Registry Software Market Share, By Country, 2020 & 2028 (%)

Figure 27 South America Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 28 South America Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 29 South America Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 30 South America Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 31 South America Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 32 South America Cancer Registry Software Market Share, By Country, 2020 & 2028 (%)

Figure 33 Europe Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 34 Europe Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 35 Europe Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 36 Europe Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 37 Europe Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 38 Europe Cancer Registry Software Market Share, By Country, 2020 & 2028 (%)

Figure 39 Asia-Pacific Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 40 Asia-Pacific Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 41 Asia-Pacific Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 42 Asia-Pacific Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 43 Asia-Pacific Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 44 Asia-Pacific Cancer Registry Software Market Share, By 0, 2020 & 2028 (%)

Figure 45 Asia-Pacific Cancer Registry Software Market Share, By Country, 2020 & 2028 (%)

Figure 46 Middle East & Africa Cancer Registry Software Market Value, 2018-2028($ Million)

Figure 47 Middle East & Africa Cancer Registry Software Market Share, By Type, 2020 & 2028 (%)

Figure 48 Middle East & Africa Cancer Registry Software Market Share, By Deployment Model, 2020 & 2028 (%)

Figure 49 Middle East & Africa Cancer Registry Software Market Share, By  Database, 2020 & 2028 (%)

Figure 50 Middle East & Africa Cancer Registry Software Market Share, By End User, 2020 & 2028 (%)

Figure 51 Siemens Healthineers : Financials

Figure 52 Onco, Inc: Financials

Figure 53 C/Net Solutions: Financials

Figure 54 Elekta AB: Financials

Figure 55 "Rocky Mountain Cancer Data Systems: Financials"

Figure 56 Electronic Registry Systems, Inc: Financials

Figure 57 Mckesson Corporation: Financials

Figure 58 Ordinal Data, Inc: Financials

Figure 59 "Conduent, Inc: Financials"

Figure 60 IBM: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest